Close

Piper Sandler Starts Avadel Pharmaceuticals (AVDL) at Overweight

February 26, 2020 4:44 AM EST Send to a Friend
Piper Sandler analyst David Amsellem initiates coverage on Avadel Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login